Expedited research and approval of medicines for drug-resistant bacterial infections in children.

Multidrug-resistant pathogens cause severe infections with substantial morbidity and mortality in neonates, infants and children, as they do in adults. However, the approval of therapies for multidrug-resistant infections in paediatric patients often lags years behind approval for adults, which crea...

Full description

Bibliographic Details
Published in:Bulletin of the World Health Organization Vol. 104; no. 8; pp. 551 - 560
Main Authors: Williams, Phoebe CM, Noel, Gary J., Nambiar, Sumati, O'Brien, Seamus, Paterson, David L., Bielicki, Julia A., Sharland, Michael, Bradley, John S.
Format: tables/charts Journal Article
Published: World Health Organization Aug2026
Online Access:View this record in EBSCOhost